Access Digital Health
CountriesSignalsInterventionsToolsAbout
Log in
← Interventions

Seasonal malaria chemoprevention (SMC)

Cost-effectiveness — what published models estimate per unit of health impact
$/DALY
see below
no $/DALY source
GiveWell
12.8×
cash multiple
CE sources
1
Tier A · 0 studies
Source agreement
—
single source
Scope to country:All countries
Loading effectiveness evidence…
Cost-effectiveness

Estimates are sourced in their native units and shown for comparison, not as literal costs. Sources use different frameworks — see each card for what it represents and how it was derived.

GiveWell program model (× cash)Tier A · program model
Malaria Consortium · seasonal malaria 2025
Geography× cashlives / M$ / lifegrant
Kebbi, Nigeria61.51,535$652$1.0M
Sokoto, Nigeria56.01,409$710$1.0M
Borno, Nigeria55.51,196$836$1.0M

GiveWell’s published mortality & grant figures per geography. Click any × cash value for full provenance and GiveWell’s own DALY-approx.

Focus a geography

Different framework — not comparable to the $/DALY axis. Native unit is multiples of cash transfers.

Data completeness: not assessed (no country selected) · Evidence confidence: not assessed (no country selected)
Delivery readiness is country-specific. Select a country in the selector above to see its health-system context — workforce density, financing mix, service coverage.
The figures above are published benchmarks. To build an investment case for your own context — local unit costs, target population, coverage assumptions — model it directly. Select a country first to carry its context into the model.
Choose a country to model →
Looking for supply/market data for Seasonal malaria chemoprevention (SMC)? Select a country above, then open its intelligence page.